European Union´s Horizon 2020 – Lipum2021-03-15T12:44:19+01:00

OFFICAL PROJECT SITE 

Novel Target for Treatment of Chronic Inflammatory Diseases — Notid

2912, 2016

Dr Einar Pontén the new CEO at Lipum AB

December 29th, 2016|

Press release Dec 29, 2016 The Board of Directors of Lipum AB in Umeå has appointed Dr Einar Pontén new CEO. "We are very pleased to recruit an experienced force when Lipum face a very exciting development," said Chairman Ulf Björklund. Link to Press release in Swedish»  

Program:
European Commission Horizon 2020
SME Instrument phase 1 No 744248
SME Instrument phase 2 No 829741

Project title:
Novel Target for Treatment of Chronic Inflammatory Diseases

Project budget:
3.2 M€

Funding from the EU:
2.2 M€

Start:
2018-11-01

End:
2020-11-30

LIPUM AB
Tvistevägen 48 C
SE-907 36 Umeå, Sweden
info@lipum.se

Privacy Policy »

All rights reserved | Copyright Lipum AB
This website uses cookies and embedded services from third parties. To change the settings and see more detailed information see our Settings Allow all cookies

Third Party Embeds

This website uses cookies and third party services. These features include embedding content such as videos or sharing website content on social media platforms. You can approve by clicking on the content that you allow to be displayed. Then save by clicking Update Settings.

Tracking Cookies

These cookies store information such as the number of visitors to the website, the number of unique visitors, which pages on the website have been visited, the source of the visit, etc. This data helps us to understand and analyze how well the website works. and where it needs to be improved.

Privacy Policy

From 25 May 2018, the General Data Protection Regulation (GDPR) applies as law in all EU member states.
Read our Privacy Policy

Contact Information

Contact us at info@lipum.se  if you have questions about how your personal data is processed by us, or if you wish us to change / delete your personal data.
Go to Top